Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Current Leases (2019 - 2025)

Arcadia Biosciences (RKDA) has disclosed Current Leases for 7 consecutive years, with $11000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Current Leases fell 98.05% year-over-year to $11000.0, compared with a TTM value of $11000.0 through Jun 2025, down 98.05%, and an annual FY2024 reading of $155000.0, down 81.81% over the prior year.
  • Current Leases was $11000.0 for Q2 2025 at Arcadia Biosciences, down from $21000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $1.1 million in Q3 2021 and bottomed at $11000.0 in Q2 2025.
  • Average Current Leases over 5 years is $754500.0, with a median of $943000.0 recorded in 2021.
  • The sharpest move saw Current Leases soared 62.0% in 2021, then tumbled 98.05% in 2025.
  • Year by year, Current Leases stood at $1.1 million in 2021, then decreased by 5.96% to $1.0 million in 2022, then fell by 15.64% to $852000.0 in 2023, then tumbled by 81.81% to $155000.0 in 2024, then plummeted by 92.9% to $11000.0 in 2025.
  • Business Quant data shows Current Leases for RKDA at $11000.0 in Q2 2025, $21000.0 in Q1 2025, and $155000.0 in Q4 2024.